Chapter 36 Treatment of gout and hyperuricemia

Alloway, 1993, Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis, J. Rheumatol., 20, 111 Bellamy, 1988, A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario, J. Rheum., 15, 1841 Campion, 1987, Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study, Amer. J. Med., 82, 421, 10.1016/0002-9343(87)90441-4 Cronstein, 1993, The adhesion molecules of inflammation, Arthritis Rheum., 36, 147, 10.1002/art.1780360204 Fessel, 1979, Renal outcomes of gout and hyperuricemia, Amer. J. Med., 67, 174, 10.1016/0002-9343(79)90076-7 Groff, 1990, Systemic steroid therapy for acute gout: A clinical trial and review of the literature, Sem. Arthr. Rheum., 19, 329, 10.1016/0049-0172(90)90070-V Hall, 1967, Epidemiology of gout and hyperuricemia. A long-term population study, Amer. J. Med., 42, 27, 10.1016/0002-9343(67)90004-6 Hande, 1984, Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency, Amer. J. Med., 76, 47, 10.1016/0002-9343(84)90743-5 Kuncl, 1987, Colchicine myopathy and neuropathy, New Engl. J. Med., 316, 1562, 10.1056/NEJM198706183162502 Liang, 1978, Asymptomatic hyperuricemia: The case for convervative management, Ann. Int. Med., 88, 666, 10.7326/0003-4819-88-5-666 Mikkelsen, 1965, The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia, Amer. J. Med., 39, 242, 10.1016/0002-9343(65)90048-3 Roberts, 1987, Colchicine in acute gout. Reassessment of risks and benefits, JAMA, 257, 1920, 10.1001/jama.1987.03390140090033 Roubenoff, 1991, Incidence and risk factors for gout in white men, JAMA, 266, 3004, 10.1001/jama.1991.03470210072035 Wallace, 1977, Preliminary criteria for the classification of the acute arthritis of primary gout, Arthr. Rheum., 20, 895, 10.1002/art.1780200320 Wallace, 1991, Renal function predicts colchicine toxicity: Guidelines for the prophylactic use of colchicine in gout, J. Rheum., 18, 264 Yü, 1967, Uric acid nephrolithiasis in gout. Predisposing factors, Ann. Int. Med., 67, 1133, 10.7326/0003-4819-67-6-1133 Yü, 1967, Principles of current management of primary gout, Amer. J. Med. Sci., 253, 893 Yü, 1982, The efficacy of colchicine prophylaxis in articular gout. A reappraisal after 20 years, Sem. Arthr. Rheum., 12, 256, 10.1016/0049-0172(82)90065-8 Yü, 1982, Impaired renal function in gout. Its association with hypertensive vascular disease and intrinsic renal disease, Amer. J. Med., 72, 95, 10.1016/0002-9343(82)90593-9